Mitsubishi UFJ Trust & Banking
MED icon

Mitsubishi UFJ Trust & Banking’s Medifast MED Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,170
Closed -$753K – 1206
2022
Q2 		$753K Hold
4,170
– – ﹤0.01% 854
2022
Q1 		$712K Buy
4,170
+70
+2% +$13.2K ﹤0.01% 958
2021
Q4 		$859K Hold
4,100
– – ﹤0.01% 954
2021
Q3 		$790K Buy
+4,100
New +$1.01M ﹤0.01% 977
2020
Q1 		– Sell
-4,000
Closed -$438K – 1317
2019
Q4 		$438K Hold
4,000
– – ﹤0.01% 1096
2019
Q3 		$415K Hold
4,000
– – ﹤0.01% 1100
2019
Q2 		$513K Buy
+4,000
New +$556K ﹤0.01% 788

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's MED Position: Q3 2022 in Review

Mitsubishi UFJ Trust & Banking sold out of Medifast (MED) in Q3 2022, closing a stake of 4,170 shares — an estimated $753K sold.

Mitsubishi UFJ Trust & Banking first reported a position in MED in Q2 2019 and held it in 7 quarters. The position peaked at $859K in Q4 2021. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Mitsubishi UFJ Trust & Banking reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 4,170 Medifast shares in Q3 2022, an estimated $753K.
  • Mitsubishi UFJ Trust & Banking first reported a position in Medifast in Q2 2019 and held it in 7 quarters.
  • Mitsubishi UFJ Trust & Banking's Medifast position peaked at $859K in Q4 2021.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q3 2022, filed 10 Nov 2022.